These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy. Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663 [TBL] [Abstract][Full Text] [Related]
6. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme. Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD Gene; 2020 Jan; 723():144126. PubMed ID: 31589963 [TBL] [Abstract][Full Text] [Related]
7. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide. Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181 [TBL] [Abstract][Full Text] [Related]
8. Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo. Sarli SL; Fakih HH; Kelly K; Devi G; Rembetsy-Brown JM; McEachern HR; Ferguson CM; Echeverria D; Lee J; Sousa J; Sleiman HF; Khvorova A; Watts JK Nucleic Acids Res; 2024 May; 52(9):4799-4817. PubMed ID: 38613388 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, Physicochemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma. Tommasini-Ghelfi S; Lee A; Mirkin CA; Stegh AH Methods Mol Biol; 2019; 1974():371-391. PubMed ID: 31099015 [TBL] [Abstract][Full Text] [Related]
10. In vivo delivery aspects of miRNA, shRNA and siRNA. Khatri N; Rathi M; Baradia D; Trehan S; Misra A Crit Rev Ther Drug Carrier Syst; 2012; 29(6):487-527. PubMed ID: 23176057 [TBL] [Abstract][Full Text] [Related]
11. Targeted electro-delivery of oligonucleotides for RNA interference: siRNA and antimiR. Chabot S; Teissié J; Golzio M Adv Drug Deliv Rev; 2015 Jan; 81():161-8. PubMed ID: 24819217 [TBL] [Abstract][Full Text] [Related]
12. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics. Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023 [TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of oligonucleotide delivery. Takeshita F; Takahashi RU; Onodera J; Ochiya T Methods Mol Biol; 2012; 872():243-53. PubMed ID: 22700416 [TBL] [Abstract][Full Text] [Related]
14. Interfering cancer with polymeric siRNA nanomedicines. Tiram G; Scomparin A; Ofek P; Satchi-Fainaro R J Biomed Nanotechnol; 2014 Jan; 10(1):50-66. PubMed ID: 24724498 [TBL] [Abstract][Full Text] [Related]
15. Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond. Krichevsky AM; Uhlmann EJ Neurotherapeutics; 2019 Apr; 16(2):319-347. PubMed ID: 30644073 [TBL] [Abstract][Full Text] [Related]
16. RNAi in clinical studies. Kubowicz P; Żelaszczyk D; Pękala E Curr Med Chem; 2013; 20(14):1801-16. PubMed ID: 23432579 [TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of small noncoding RNA for glioblastoma. Yoo JY; Yeh M; Kaur B; Lee TJ Cancer Lett; 2021 Mar; 500():274-280. PubMed ID: 33176185 [TBL] [Abstract][Full Text] [Related]
18. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials. Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225 [TBL] [Abstract][Full Text] [Related]
19. Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma. Michiue H; Eguchi A; Scadeng M; Dowdy SF Cancer Biol Ther; 2009 Dec; 8(23):2306-13. PubMed ID: 19901546 [TBL] [Abstract][Full Text] [Related]
20. RNA interference and cancer therapy. Wang Z; Rao DD; Senzer N; Nemunaitis J Pharm Res; 2011 Dec; 28(12):2983-95. PubMed ID: 22009588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]